EpiPen Maker Overcharged Taxpayers for Years, Officials Say

The maker of EpiPens overcharged the Medicaid program for years by misclassifying its product, the Obama administration says. Democratic lawmakers released a letter on Wednesday from Andy Slavitt, head of the Centers for Medicare and Medicaid Services (CMS), confirming that EpiPen maker Mylan had misclassified the device — in effect, overcharging taxpayers for its product.